Skip To Main Content
Noud van Helmond on Muck Rack

Noud van Helmond

As seen in: PLOS ONE, MDPI, JoVE- Journal of Visualized Experiments
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Noud

Contact Noud, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

The optimal warming strategy to reduce perioperative hypothermia: A prospective randomized non-blinded clinical trial

|
By Ronak D. Desai, New jersey, Noud van Helmond, Jason Gosschalk
| PLOS ONE
Loading metrics Open Access Peer-reviewed Research Article Citation: Desai R, Gosschalk J, van Helmond N, Mitrev L, Zhang C, McEniry B, et al. (2025) The optimal warming strategy to reduce perioperative hypothermia: A prospective randomized non-blinded clinical trial. PLoS One 20(6): e0325954.
Open in Who Shared Issue with article?

Nutrients | Free Full-Text | Healthcare Costs and Healthcare Utilization Outcomes of Vitamin D3 Supplementation at 5000 IU Daily during a 10.9 Month Observation Period within a Pragmatic Randomized Clinical Trial

|
By Patrick J. LaRiccia, Teresa Cafaro, Dibato John, Noud van Helmond
| MDPI
1. Introduction Healthcare costs and healthcare utilization continue to rise [1,2,3,4]. Likewise, the expense of medical insurance has become prohibitive for many families and small businesses [5]. According to a survey in 2009, US workers reported paying double their insurance premiums over the preceding decade. Employees’ premium costs rose from USD 1543 on average in 1999 to USD 3515 in 2009 [6].
Open in Who Shared Issue with article?

Mortality in individuals treated with COVID-19 convalescent plasma varies with the geographic provenance of donors

|
By Katie L. Kunze, Patrick Johnson, Noud van Helmond, Jonathon W. Senefeld
| medRxiv
Abstract Treatment and prevention of coronavirus disease 2019 (COVID-19) have attempted to harness the immune response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) including the development of successful COVID-19 vaccines and therapeutics (e.g., Remdesivir, convalescent plasma [CP]). Evidence that SARS-CoV-2 exists as quasispecies evolving locally suggests that immunological differences may exist that could impact the effectiveness of antibody-based treatments and vaccines.
Open in Who Shared Issue with article?
See all 7 licensed articles (8 Total)